Rocket Pharmaceuticals (RCKT) Stock Forecast & Price Target

→ Your Next Portfolio Star: Revealing 2024's Top Stock Pick (From Darwin) (Ad)

$23.68

-0.57 (-2.35%)

(As of 04/17/2024 ET)

Rocket Pharmaceuticals Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Moderate Buy
Based on 9 Analyst Ratings

Analysts' Consensus Price Target

$52.13
120.12% Upside

High Forecast	$65.00
Average Forecast	$52.13
Low Forecast	$39.00

Type	Current Forecast 4/19/23 to 4/18/24	1 Month Ago 3/20/23 to 3/19/24	3 Months Ago 1/19/23 to 1/19/24	1 Year Ago 4/19/22 to 4/19/23
Consensus Rating	Moderate Buy	Buy	Buy	Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	8 Buy rating(s)	9 Buy rating(s)	9 Buy rating(s)	11 Buy rating(s)
Hold	1 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$52.13	$54.00	$52.57	$52.55
Predicted Upside	120.12% Upside	116.19% Upside	174.57% Upside	203.97% Upside

Get Rocket Pharmaceuticals Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for RCKT and its competitors with MarketBeat's FREE daily newsletter.

Ad DTI

With the “Bitcoin Loophole” you can supercharge the gains by 10x or more

Thanks to this newly discovered Bitcoin Loophole, you can now trade Bitcoin in any regular brokerage account… And not only that… you can use it to supercharge the gains of Bitcoin by 10x or more! You see, thanks to one unique investor's brand new discovery - anyone with a regular brokerage account can now tap into the most explosive asset in history. That means you can skip the hassle of opening a Coinbase account… Bypass the fees and hard-to-remember passwords…

RCKT Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

RCKT Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Rocket Pharmaceuticals Stock vs. The Competition

Type	Rocket Pharmaceuticals	Medical Companies	S&P 500
Consensus Rating Score	2.89	2.68	2.49
Consensus Rating	Moderate Buy	Moderate Buy	Hold
Predicted Upside	120.12% Upside	927.62% Upside	12.25% Upside
News Sentiment Rating	Neutral News	Neutral News	Positive News

Recent Analyst Ratings and Stock Forecasts

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
4/10/2024	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$53.00	+109.07%
4/2/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Neutral	$39.00	+45.96%
3/1/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$56.00 ➝ $54.00	+75.84%
2/27/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$55.00 ➝ $50.00	+62.81%
2/27/2024	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Overweight ➝ Overweight	$65.00	+118.27%
12/26/2023	Lifesci Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Jubinville Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform
9/13/2023	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$48.00	+124.30%
8/11/2023	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$49.00 ➝ $47.00	+180.10%
8/11/2023	Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$61.00	+263.53%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 07:27 AM ET.

RCKT Price Target - Frequently Asked Questions

What is Rocket Pharmaceuticals's consensus rating and price target?: According to the issued ratings of 9 analysts in the last year, the consensus rating for Rocket Pharmaceuticals stock is Moderate Buy based on the current 1 hold rating and 8 buy ratings for RCKT. The average twelve-month price prediction for Rocket Pharmaceuticals is $52.13 with a high price target of $65.00 and a low price target of $39.00. Learn more on RCKT's analyst rating history.
Do Wall Street analysts like Rocket Pharmaceuticals more than its competitors?: Analysts like Rocket Pharmaceuticals more than other Medical companies. The consensus rating score for Rocket Pharmaceuticals is 2.89 while the average consensus rating score for medical companies is 2.68. Learn more on how RCKT compares to other companies.
Does Rocket Pharmaceuticals's stock price have much upside?: According to analysts, Rocket Pharmaceuticals's stock has a predicted upside of 110.36% based on their 12-month stock forecasts.

What analysts cover Rocket Pharmaceuticals?: Rocket Pharmaceuticals has been rated by Cantor Fitzgerald, JPMorgan Chase & Co., Needham & Company LLC, The Goldman Sachs Group, and UBS Group in the past 90 days.

Stock Ratings Reports and Tools

Related Companies:

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

This page (NASDAQ:RCKT) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Rocket Pharmaceuticals (RCKT) Stock Forecast & Price Target

Rocket Pharmaceuticals Consensus Analyst Rating and Stock Price Forecast (2024)

Analysts' Consensus Rating

Analysts' Consensus Price Target

RCKT Analyst Ratings By Month

RCKT Price Targets by Month

Rocket Pharmaceuticals Stock vs. The Competition

Recent Analyst Ratings and Stock Forecasts

RCKT Price Target - Frequently Asked Questions

Stock Ratings Reports and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info